TSDCA raids several clinics across Telangana; Seizes medicines sold with misleading claims

The Numine-100 Tablets was falsely manufactured under a ‘food license (FSSAI license)’ and falsely claimed to be a food product/nutraceutical. According to the label composition of the product, it is classified as a drug under the Drugs and Cosmetics Act, 1940

Hyderabad: The drug inspectors of Telangana State Drug Control Administration (TSDCA) have detected Numine-100 Tablets (Thiamine Tablets 100mg), that were circulating in Peddapalli and were falsely manufactured and sold under the guise of ‘food products/nutraceuticals’.

The drugs were manufactured by MK Biotech, Sangrur, Punjab and marketed by Neuracle Lifesciences, Chandigarh.

The said product was falsely manufactured under a ‘food license (FSSAI license)’ and falsely claimed to be a food product/nutraceutical. According to the label composition of the product, it is classified as a drug under the Drugs and Cosmetics Act, 1940.

The product must be manufactured only under a ‘drug licence’ issued under the Drugs and Cosmetics Act, adhering strictly to the ‘Good Manufacturing Practices’ (GMP) outlined in Schedule-M of the Drugs Rules. Additionally, it must meet the quality standards prescribed in the ‘Indian Pharmacopoeia’ (IP) as mandated, DG, TSDCA, V B Kamalsan Reddy said.

In another unrelated event, the DCA teams detected medicines circulating in the market with misleading claims on their labels, stating that they treat diabetes and ‘For Prophylaxis and treatment of Eye Infections’. Such claims are in contravention of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

The medicines that were seized in Mancherial include EYECARE Eye ointment (allopathic medicine) manufactured by Chandra Drugs, Indore, Madhya Pradesh were making a misleading claim of prophylaxis and treatment of eye infections.

Another medicine Vatti-Veru Churna (Ayurvedic), manufactured by Akheera Drugs, Balanagar, Medchal-Malkajgiri, was detected and seized in Balanagar for making false claims of treating diabetes.

Advertising a medicine for the treatment of ‘Diabetes’ and ‘For Prophylaxis and treatment of Eye Infections’ is prohibited under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 / Schedule J of Drugs Rules, 1945, DG, TSDCA said.